21 C.F.R. § 864.7360

Erythrocytic glucose-6-phosphate dehydrogenase assay.

Last amended: 2016Year: 2026Length: 80 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 864.7360 (2026)

(a) Identification. An erythrocytic glucose-6-phosphate dehydrogenase assay is a device used to measure the activity of the enzyme glucose-6-phosphate dehydrogenase or of glucose-6-phosphate dehydrogenase isoenzymes. The results of this assay are used in the diagnosis and treatment of nonspherocytic congenital hemolytic anemia or drug-induced hemolytic anemia associated with a glucose-6-phosphate dehydrogenase deficiency. This generic device includes assays based on fluorescence, electrophoresis, methemoglobin reduction, catalase inhibition, and ultraviolet kinetics. (b) Classification. Class II (performance standards). [45 FR 60616, Sept. 12, 1980]
21 C.F.R. § 864.7360: Erythrocytic glucose-6-phosphate dehydrogenase assay. | Justis AI